Quality control indices for standardized diagnosis and treatment of esophageal cancer in China (2022 edition)
Esophageal cancer (EC) is particularly common in China. With the continuing progress of multi-disciplinary therapy including early screening, minimally invasive techniques, radiotherapy and chemotherapy, the 5-year survival of EC has been improved in China. However, there are considerable disparitie...
Main Authors: | Ruixiang Zhang, Zhen Wang, Xiaozheng Kang, Xin Wang, Bo Zhang, Hoi-loi Ng, Liyan Xue, Wenjing Yang, Liming Shi, Hui Wang, Lvhua Wang, Yin Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | Journal of the National Cancer Center |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667005423000455 |
Similar Items
-
Chinese quality control indices for standardized diagnosis and treatment of renal cancer (2022 edition)
by: Lin Yao, et al.
Published: (2024-03-01) -
Phase Ib trial of camrelizumab combined with chemotherapy and apatinib for neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma
by: Zhen Wang, et al.
Published: (2022-06-01) -
Eosinophilic esophagitis and esophageal microbiota
by: Xiaohan Zhang, et al.
Published: (2023-08-01) -
Characterization of Esophageal Microbiota in Patients With Esophagitis and Esophageal Squamous Cell Carcinoma
by: Zongdan Jiang, et al.
Published: (2021-11-01) -
Treatment mode and prognosis of esophageal perforation after radiotherapy in patients with esophageal carcinoma
by: Zhen Chan-Jun, et al.
Published: (2023-01-01)